Analysis of the TCGA glioblastoma dataset and the French glioma dataset gse16011 [26], showed no variation in ARNT2 expression according to MGMT status, IDH1 mutation or EGFR amplification (not shown). Here, MGMT is linked to central nervous system cancer.